 |
Parkinsons News: 273 headlines |
|
|||||
Celebrity Fight Night Video  |
||||||||
|
||||||||
|
||||||||
| Sources used by our Parkinsons News Channel Research Team: | ||||||||
| The New York Times, CNN, FOX, CBS, BBC, Mayo Clinic, Johns Hopkins Medicine, UCLA Medical Center, National Institute of Health, Stanford Hospital, Memorial Sloan- Kettering, Yale Cancer Center, Massachusetts General Hospital, Brigham and Women's Hospital, University of Michigan, M. D. Anderson Cancer Center, National Institute of Health, American Cancer Association, NBC, Reuters News, American College of Cardiology, Journal of the American Medical Association & 100's more | ||||||||
| Links | ||||||||
| Barrow Neurological Institute | ||||||||
| Archives |
Wednesday
Myriad Genetics progressing with phase III Flurizan study :
"Flurizan is the first in a new class of investigative drugs known as selective amyloid lowering agents, or SALAs. This mechanism is different from the currently marketed drugs for Alzheimer's disease that provide only a limited, temporary cognitive boost without affecting the course of the disease itself......"
"Flurizan is the first in a new class of investigative drugs known as selective amyloid lowering agents, or SALAs. This mechanism is different from the currently marketed drugs for Alzheimer's disease that provide only a limited, temporary cognitive boost without affecting the course of the disease itself......"